Comparative efficacy and safety of tenofovir amibufenamide vs tenofovir alafenamide in the initial 48-week treatment of high viral load chronic hepatitis B: A single-centre retrospective study.
Qing ZhangJianhua XuDan LiuLilin WangShan RenSujun ZhengXinyue ChenLi QiJunfeng LuPublished in: Antiviral therapy (2024)
TMF demonstrates comparable antiviral efficacy to TAF when used as initial therapy in highly viremic CHB patients, with similar impacts on renal function and lipid profiles.